What we are doing here at Danone is really keeping an eye on the research literature, she added, asking: As more studies come out that include dietary data on individuals taking GLP-1s, is there an opportunity for us to evolve our portfolio along with it? Oikos Fusion and Oikos Protein Shakes underscore GLP-1 users diverse needs The answer is yes, but Danone isnt waiting to meet the unique needs of GLP-1 users
One in eight Americans are taking or have taken a glucagon-like peptide-1 receptor agonist (GLP-1)
Kumar says that retatrutide will likely be best suited for "people who we consider non-responders to existing cardiometabolic medications," such as Wegovy and Ozempic
One of these convicted fraudsters, Mihir Taneja, pleaded guilty on November 30, 2020, to introduction of misbranded drugs into interstate commerce with the intent to defraud and mislead. He was sentenced to 10 months in prison followed by one year of supervised release and was ordered to pay almost $21 million
Patients who understand this distinction tend to have more realistic expectations than those who treat a chart as a fixed countdown
What Investigators Found Investigators cited a list of quality-control problems: vials that were mislabeled, medications not dispensed in child-resistant containers, and doses with no tracking numbers or expiration dates